Statistically significant effectiveness proven in clinical studies on over 1000 patients. These studies were done against a placebo or comparator, providing the highest level of scientific evidence.
This first study demonstrates the benefits of using DEXERYL Emollient Cream in the treatment of dry skin conditions in the context of mild to moderate atopic dermatitis in children.
DEXERYL Emollient Cream significantly reduces and delays the number of flare-ups compared to untreated patients1
Pourcentage de patients ayant au moins 1 poussée inflammatoire d’eczéma confirmée durant les 3 mois du test comparé à des patients non traités. Graphique créé par Pierre Fabre.
dry skin at 12 weeks according to parents¹
fewer patients used corticosteroids²
To demonstrate the benefits of using Dexeryl in the treatment of mild to moderate atopic dermatitis in children, by assessing the ability of Dexeryl to prevent flare-ups and reduce the use of corticosteroids.
International, multicentre, randomised, parallel, open-label.
335 children aged 2 to 6 years with mild to moderate atopic dermatitis, recruited during a flare-up and treated with a strong topical corticosteroid and finally randomised once the lesions had cleared up (111 treated with Dexeryl, 116 treated with the reference emollient and 108 without emollient treatment).
Dexeryl twice a day on the whole body, reference emollient three times a day on the affected areas of the body.
12 weeks (intermediate evaluations after 4 and 8 weeks).
Percentage of patients with at least one flare-up after 12 weeks.
Time to first flare-up, time to complete remission, number of flare-ups, percentage of patients requiring corticosteroids or immunosuppressants at weeks 4, 8 and 12, corticosteroid use.
Good tolerance was observed.
dryness perceived by the user¹
found an improvement in the child's well-being¹
sensations of itching¹
found DEXERYL easy to apply¹
The cleansing oil that cares for all dry and atopy-prone skin in the shower
itching due to dry skin after 15 days¹
effective from the 1st use¹
xerosis at 3 weeks¹
of users report that their skin is intensely nourished immediately after application¹
Efficacy and skin and eye tolerance study of DEXERYL Cleansing Oil on 43 subjects with atopic dermatitis.
Single-centre, open-label, non-randomised under dermatological, paediatric and ophthalmological control.
43 patients: infants (3-23 months), children, adults with mild atopic dermatitis (15 ≤ SCORAD ≥ 25) and dry or very dry skin (Xerosis >1 and at least 30% of subjects with xerosis >2) and not during a flare-up.
DEXERYL Cleansing Oil was used: once or twice a day on the face and body (depending on hygiene habits).
two days with an intermediate evaluation at 15 days.
Evaluation of skin tolerance on the face and body. Evaluation of the overall dermatological tolerance after the end of the study. Assessment of ocular tolerance.
Evaluation of the evolution of SCORAD. Assessment of cosmetic acceptability and perceived effectiveness of the product by the subjects.
Excellent skin tolerance. Excellent eye tolerance: does not sting the eyes, does not cause watering or irritation.
Formulated to gently cleanse dry or atopy-prone skin, it helps to strengthen the skin barrier, durably protects the skin from drying out and soothes tightness. It contains vaseline, paraffin and glycerol and is formulated without fragrance.
Apply to wet skin, lather gently and rinse thoroughly. After drying your skin, applying Dexeryl Emollient Cream is recommended.
of users reported feeling that their skin felt hydrated¹
of users reported feeling relief from dry skin¹
itching¹
Discover the DEXERYL range
Atopic eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease.
Sources:
1- Tiplica G.S. et al. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomised controlled study. JEADV 2018
2- Tiplica G.S. et al. Prevention of flares in children with atopic dermatitis with regular use of an emollient containing glycerol and paraffin: a randomized controlled study. Pediatric Dermatology 2017
